Inhibition of catechol-O-methyltransferase by N-(3,4-dihydroxyphenyl) maleimide

J Enzyme Inhib. 1990;4(1):43-50. doi: 10.3109/14756369009030387.

Abstract

Catechol-O-methyltransferase (COMT) is inhibited rapidly and irreversibly by N-(3,4-dihydroxyphenyl) maleimide. S-adenosylmethionine (AdoMet) and magnesium ions protect the enzyme from inactivation by this compound, but no protection is observed by the catechol substrate. However, the corresponding succinimide analogue shows a reversible inhibition of COMT, which is competitive with pyrocatecholphthalein and non-competitive with AdoMet. Amino-group reagents also inhibit COMT and this inhibition is protected by AdoMet, suggesting that sulphydryl and amino groups essential for activity are located in an AdoMet-binding site on COMT. The maleimide derivative may be considered to be an active-site directed inhibitor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Binding, Competitive
  • Catechol O-Methyltransferase / isolation & purification
  • Catechol O-Methyltransferase Inhibitors*
  • Catechols / pharmacology*
  • Kinetics
  • Liver / enzymology
  • Magnesium / pharmacology
  • Maleimides / pharmacology*
  • Molecular Structure
  • Swine
  • Thiourea / analogs & derivatives
  • Thiourea / pharmacology

Substances

  • Catechol O-Methyltransferase Inhibitors
  • Catechols
  • Maleimides
  • N-(3,4-dihydroxyphenyl)maleimide
  • Catechol O-Methyltransferase
  • Thiourea
  • Magnesium